ChemSpider 28536140 Formula C25H21F4N3O3 Molar mass 487.446 g/mol | UNII 641H0Q518W 3D model (Jmol) Interactive image | |
 | ||
AZD5423 is a nonsteroidal glucocorticoid and phase II drug by AstraZeneca disclosed at the spring 2013 American Chemical Society meeting in New Orleans to treat respiratory diseases and in particular chronic obstructive pulmonary disease.
References
AZD5423 Wikipedia(Text) CC BY-SA